O	0	1	2	2	CD	B-NP
O	1	2	.	.	.	I-NP
O	2	3	1	1	CD	I-NP
O	3	4	.	.	.	O

O	5	15	Biological	Biological	JJ	B-NP
B-Multi-tissue_structure	16	23	samples	sample	NNS	I-NP

B-Tissue	24	33	Placental	Placental	JJ	B-NP
I-Tissue	34	41	tissues	tissue	NNS	I-NP
O	42	46	from	from	IN	B-PP
O	47	50	the	the	DT	B-NP
O	51	56	first	first	JJ	I-NP
O	57	66	trimester	trimester	NN	I-NP
O	67	74	legally	legally	RB	B-NP
O	75	82	induced	induce	VBN	I-NP
O	83	92	abortions	abortion	NNS	I-NP
O	93	94	(	(	(	O
O	94	95	8	8	CD	B-NP
O	95	96	-	-	HYPH	I-NP
O	96	98	12	12	CD	I-NP
O	99	104	weeks	week	NNS	I-NP
O	105	107	of	of	IN	B-PP
O	108	117	gestation	gestation	NN	B-NP
O	117	118	)	)	)	O
O	119	123	were	be	VBD	B-VP
O	124	132	obtained	obtain	VBN	I-VP
O	133	137	from	from	IN	B-PP
O	138	141	the	the	DT	B-NP
O	142	152	Department	Department	NNP	I-NP
O	153	155	of	of	IN	B-PP
O	156	166	Obstetrics	Obstetrics	NNP	B-NP
O	167	170	and	and	CC	I-NP
O	171	181	Gynecology	Gynecology	NNP	I-NP
O	182	184	at	at	IN	B-PP
O	185	188	the	the	DT	B-NP
O	189	198	Broussais	Broussais	NNP	I-NP
O	198	199	,	,	,	I-NP
O	200	205	Saint	Saint	NNP	I-NP
O	206	213	Vincent	Vincent	NNP	I-NP
O	214	216	de	de	IN	I-NP
O	217	221	Paul	Paul	NNP	I-NP
O	222	225	and	and	CC	I-NP
O	226	232	Cochin	Cochin	NNP	I-NP
O	233	242	Hospitals	Hospitals	NNP	I-NP
O	242	243	.	.	.	O

O	244	250	Second	Second	JJ	B-NP
O	251	260	trimester	trimester	NN	I-NP
B-Tissue	261	270	placental	placental	JJ	I-NP
I-Tissue	271	278	tissues	tissue	NNS	I-NP
O	279	283	were	be	VBD	B-VP
O	284	293	collected	collect	VBN	I-VP
O	294	296	at	at	IN	B-PP
O	297	300	the	the	DT	B-NP
O	301	305	time	time	NN	I-NP
O	306	308	of	of	IN	B-PP
O	309	320	termination	termination	NN	B-NP
O	321	323	of	of	IN	B-PP
O	324	333	pregnancy	pregnancy	NN	B-NP
O	334	336	at	at	IN	B-PP
O	337	339	15	15	CD	B-NP
O	340	343	and	and	CC	I-NP
O	344	346	25	25	CD	I-NP
O	347	352	weeks	week	NNS	I-NP
O	353	355	of	of	IN	B-PP
O	356	365	gestation	gestation	NN	B-NP
O	366	367	(	(	(	O
O	367	369	in	in	IN	B-PP
O	370	375	weeks	week	NNS	B-NP
O	376	378	of	of	IN	B-PP
O	379	389	amenorrhea	amenorrhea	NN	B-NP
O	389	390	)	)	)	O
O	391	393	in	in	IN	B-PP
O	394	401	trisomy	trisomy	NN	B-NP
O	402	404	21	21	CD	I-NP
O	404	405	-	-	HYPH	B-NP
O	405	413	affected	affect	VBN	I-NP
O	414	425	pregnancies	pregnancy	NNS	I-NP
O	425	426	.	.	.	O

B-Developing_anatomical_structure	427	432	Fetal	Fetal	JJ	B-NP
O	433	437	Down	Down	NN	I-NP
O	438	446	syndrome	syndrome	NN	I-NP
O	447	450	was	be	VBD	B-VP
O	451	460	diagnosed	diagnose	VBN	I-VP
O	461	463	by	by	IN	B-PP
O	464	475	karyotyping	karyotyping	NN	B-NP
O	476	478	of	of	IN	B-PP
B-Cell	479	487	amniotic	amniotic	JJ	B-NP
I-Cell	488	493	fluid	fluid	NN	I-NP
I-Cell	494	499	cells	cell	NNS	I-NP
O	499	500	.	.	.	O

O	501	504	The	The	DT	B-NP
O	505	515	indication	indication	NN	I-NP
O	516	518	of	of	IN	B-PP
O	519	532	amniocentesis	amniocentesis	NN	B-NP
O	533	536	was	be	VBD	B-VP
O	537	540	the	the	DT	B-NP
O	541	549	maternal	maternal	JJ	I-NP
O	550	553	age	age	NN	I-NP
O	553	554	.	.	.	O

O	555	559	Term	Term	NN	B-NP
B-Organ	560	569	placentas	placenta	NNS	I-NP
O	570	574	were	be	VBD	B-VP
O	575	583	obtained	obtain	VBN	I-VP
O	584	589	after	after	IN	B-PP
O	590	598	elective	elective	JJ	B-NP
O	599	607	cesarean	cesarean	JJ	I-NP
O	608	615	section	section	NN	I-NP
O	616	620	from	from	IN	B-PP
O	621	628	healthy	healthy	JJ	B-NP
O	629	636	mothers	mother	NNS	I-NP
O	637	641	near	near	IN	B-PP
O	642	646	term	term	NN	B-NP
O	647	651	with	with	IN	B-PP
O	652	665	uncomplicated	uncomplicated	JJ	B-NP
O	666	677	pregnancies	pregnancy	NNS	I-NP
O	677	678	.	.	.	O

O	679	683	With	With	IN	B-SBAR
O	684	691	written	write	VBN	B-NP
O	692	700	informed	inform	VBN	I-NP
O	701	708	consent	consent	NN	I-NP
O	709	711	of	of	IN	B-PP
O	712	715	the	the	DT	B-NP
O	716	724	pregnant	pregnant	JJ	I-NP
O	725	730	woman	woman	NN	I-NP
O	730	731	,	,	,	O
O	732	735	the	the	DT	B-NP
O	736	745	following	follow	VBG	I-NP
B-Multi-tissue_structure	746	753	samples	sample	NNS	I-NP
O	754	758	were	be	VBD	B-VP
O	759	768	collected	collect	VBN	I-VP
O	769	771	at	at	IN	B-PP
O	772	776	term	term	NN	B-NP
O	776	777	:	:	:	O
O	778	779	a	a	DT	B-NP
B-Multi-tissue_structure	780	788	fragment	fragment	NN	I-NP
O	789	791	of	of	IN	B-PP
O	792	795	the	the	DT	B-NP
B-Organ	796	804	placenta	placenta	NN	I-NP
O	804	805	,	,	,	O
B-Organism_substance	806	815	umbilical	umbilical	JJ	B-NP
I-Organism_substance	816	820	cord	cord	NN	I-NP
I-Organism_substance	821	826	fetal	fetal	JJ	I-NP
I-Organism_substance	827	832	blood	blood	NN	I-NP
O	833	836	and	and	CC	O
O	837	845	maternal	maternal	JJ	B-NP
B-Organism_substance	846	851	blood	blood	NN	I-NP
O	851	852	.	.	.	O

O	853	856	The	The	DT	B-NP
B-Multi-tissue_structure	857	865	placenta	placenta	NN	I-NP
I-Multi-tissue_structure	866	872	biopsy	biopsy	NN	I-NP
I-Multi-tissue_structure	873	879	sample	sample	NN	I-NP
O	880	883	was	be	VBD	B-VP
O	884	893	collected	collect	VBN	I-VP
O	894	896	at	at	IN	B-PP
O	897	898	a	a	DT	B-NP
O	899	904	depth	depth	NN	I-NP
O	905	907	of	of	IN	B-PP
O	908	909	1	1	CD	B-NP
O	910	912	cm	cm	NN	I-NP
O	913	916	and	and	CC	B-PP
O	917	919	at	at	IN	B-PP
O	920	921	a	a	DT	B-NP
O	922	930	distance	distance	NN	I-NP
O	931	933	of	of	IN	B-PP
O	934	935	8	8	CD	B-NP
O	936	938	cm	cm	NN	I-NP
O	939	943	from	from	IN	B-PP
O	944	947	the	the	DT	B-NP
O	948	952	edge	edge	NN	I-NP
O	953	955	of	of	IN	B-PP
O	956	959	the	the	DT	B-NP
B-Organ	960	968	placenta	placenta	NN	I-NP
O	968	969	,	,	,	O
O	970	974	with	with	IN	B-PP
O	975	978	the	the	DT	B-NP
O	979	987	maternal	maternal	JJ	I-NP
O	988	992	side	side	NN	I-NP
O	993	999	facing	face	VBG	B-VP
O	1000	1006	upward	upward	RB	B-ADVP
O	1006	1007	.	.	.	O

O	1008	1011	The	The	DT	B-NP
O	1012	1015	use	use	NN	I-NP
O	1016	1018	of	of	IN	B-PP
O	1019	1024	these	these	DT	B-NP
O	1025	1035	biological	biological	JJ	I-NP
B-Multi-tissue_structure	1036	1043	samples	sample	NNS	I-NP
O	1044	1047	was	be	VBD	B-VP
O	1048	1056	approved	approve	VBN	I-VP
O	1057	1059	by	by	IN	B-PP
O	1060	1065	local	local	JJ	B-NP
O	1066	1073	ethical	ethical	JJ	I-NP
O	1074	1083	committee	committee	NN	I-NP
O	1083	1084	.	.	.	O

B-Cell	1085	1092	Villous	Villous	JJ	B-NP
I-Cell	1093	1110	cytotrophoblastic	cytotrophoblastic	JJ	I-NP
I-Cell	1111	1116	cells	cell	NNS	I-NP
O	1117	1121	were	be	VBD	B-VP
O	1122	1130	isolated	isolate	VBN	I-VP
O	1131	1133	by	by	IN	B-PP
O	1134	1144	sequential	sequential	JJ	B-NP
O	1145	1154	enzymatic	enzymatic	JJ	I-NP
O	1155	1164	digestion	digestion	NN	I-NP
O	1165	1167	of	of	IN	B-PP
B-Multi-tissue_structure	1168	1177	chorionic	chorionic	JJ	B-NP
I-Multi-tissue_structure	1178	1183	villi	villus	NNS	I-NP
O	1184	1188	from	from	IN	B-PP
O	1189	1192	the	the	DT	B-NP
O	1193	1198	first	first	JJ	I-NP
O	1199	1208	trimester	trimester	NN	I-NP
O	1208	1209	,	,	,	O
O	1210	1216	second	second	JJ	B-NP
O	1217	1226	trimester	trimester	NN	I-NP
O	1227	1230	and	and	CC	O
O	1231	1235	term	term	NN	B-NP
B-Organ	1236	1244	placenta	placenta	NN	I-NP
O	1245	1248	and	and	CC	O
O	1249	1257	purified	purify	VBN	B-VP
O	1258	1260	on	on	IN	B-PP
O	1261	1262	a	a	DT	B-NP
O	1263	1276	discontinuous	discontinuous	JJ	I-NP
O	1277	1284	percoll	percoll	NN	I-NP
O	1285	1293	gradient	gradient	NN	I-NP
O	1293	1294	,	,	,	O
O	1295	1297	as	as	IN	B-SBAR
O	1298	1307	described	describe	VBN	B-VP
O	1308	1318	previously	previously	RB	B-ADVP
O	1318	1319	.	.	.	O
O	1319	1321	47	47	CD	B-NP
O	1321	1322	-	-	HYPH	I-NP
O	1322	1324	49	49	CD	I-NP
O	1325	1330	These	These	DT	B-NP
B-Cell	1331	1336	cells	cell	NNS	I-NP
O	1337	1341	were	be	VBD	B-VP
O	1342	1352	positively	positively	RB	I-VP
O	1353	1360	stained	stain	VBN	I-VP
O	1361	1364	for	for	IN	B-PP
O	1365	1376	cytokeratin	cytokeratin	NN	B-NP
O	1377	1378	7	7	CD	I-NP
O	1379	1381	at	at	IN	B-PP
O	1382	1384	95	95	CD	B-NP
O	1384	1385	%	%	NN	I-NP
O	1385	1386	,	,	,	O
O	1387	1397	indicating	indicate	VBG	B-VP
O	1398	1401	the	the	DT	B-NP
O	1402	1419	cytotrophoblastic	cytotrophoblastic	JJ	I-NP
O	1420	1426	origin	origin	NN	I-NP
O	1427	1429	of	of	IN	B-PP
O	1430	1433	the	the	DT	B-NP
B-Cell	1434	1439	cells	cell	NNS	I-NP
O	1439	1440	.	.	.	O

B-Cell	1441	1450	Placental	Placental	JJ	B-NP
I-Cell	1451	1462	fibroblasts	fibroblast	NNS	I-NP
O	1463	1467	were	be	VBD	B-VP
O	1468	1476	isolated	isolate	VBN	I-VP
O	1477	1479	by	by	IN	B-PP
O	1480	1489	prolonged	prolonged	JJ	B-NP
O	1490	1499	enzymatic	enzymatic	JJ	I-NP
O	1500	1509	digestion	digestion	NN	I-NP
O	1510	1514	from	from	IN	B-PP
O	1515	1520	first	first	JJ	B-NP
O	1521	1530	trimester	trimester	NN	I-NP
B-Multi-tissue_structure	1531	1540	chorionic	chorionic	JJ	I-NP
I-Multi-tissue_structure	1541	1546	villi	villus	NNS	I-NP
O	1547	1549	as	as	IN	B-PP
O	1550	1552	in	in	IN	B-PP
O	1553	1562	Malassine	Malassine	NNP	B-NP
O	1563	1565	et	et	FW	I-NP
O	1566	1568	al	al	FW	I-NP
O	1568	1569	.	.	.	O
O	1569	1571	50	50	CD	B-NP
B-Cell	1572	1584	Fibroblastic	Fibroblastic	JJ	I-NP
I-Cell	1585	1590	cells	cell	NNS	I-NP
O	1591	1592	(	(	(	O
O	1592	1593	1	1	CD	B-NP
O	1593	1594	.	.	.	O
O	1594	1596	25	25	CD	B-NP
O	1597	1598	x	x	CC	I-NP
O	1599	1602	105	105	CD	I-NP
O	1603	1608	cells	cell	NNS	I-NP
O	1608	1609	/	/	SYM	O
O	1609	1611	mL	mL	NN	B-NP
O	1611	1612	)	)	)	O
O	1613	1617	were	be	VBD	B-VP
O	1618	1624	plated	plat	VBN	I-VP
O	1625	1627	on	on	IN	B-PP
O	1628	1630	35	35	CD	B-NP
O	1630	1631	-	-	HYPH	I-NP
O	1631	1633	mm	mm	NN	I-NP
O	1634	1641	plastic	plastic	NN	I-NP
O	1642	1648	dishes	dish	NNS	I-NP
O	1649	1650	(	(	(	O
O	1650	1653	TPP	TPP	NN	B-NP
O	1653	1654	,	,	,	O
O	1655	1666	Switzerland	Switzerland	NNP	B-NP
O	1666	1667	)	)	)	O
O	1668	1671	and	and	CC	O
O	1672	1680	cultured	culture	VBN	B-VP
O	1681	1684	for	for	IN	B-PP
O	1685	1687	48	48	CD	B-NP
O	1688	1689	h	h	NN	I-NP
O	1689	1690	,	,	,	O
O	1691	1694	and	and	CC	O
O	1695	1698	the	the	DT	B-NP
O	1699	1706	culture	culture	NN	I-NP
O	1707	1713	medium	medium	NN	I-NP
O	1714	1717	was	be	VBD	B-VP
O	1718	1725	changed	change	VBN	I-VP
O	1726	1731	daily	daily	RB	B-ADVP
O	1731	1732	.	.	.	O

O	1733	1738	These	These	DT	B-NP
O	1739	1747	cultured	culture	VBN	I-NP
B-Cell	1748	1759	fibroblasts	fibroblast	NNS	I-NP
O	1760	1764	were	be	VBD	B-VP
O	1765	1778	characterized	characterize	VBN	I-VP
O	1779	1784	using	use	VBG	B-VP
O	1785	1804	immunocytochemistry	immunocytochemistry	NN	B-NP
O	1804	1805	.	.	.	O

O	1806	1808	It	It	PRP	B-NP
O	1809	1812	was	be	VBD	B-VP
O	1813	1818	found	find	VBN	I-VP
O	1819	1823	that	that	IN	B-SBAR
O	1824	1826	98	98	CD	B-NP
O	1826	1827	%	%	NN	I-NP
O	1828	1830	of	of	IN	B-PP
O	1831	1834	the	the	DT	B-NP
B-Cell	1835	1840	cells	cell	NNS	I-NP
O	1841	1845	were	be	VBD	B-VP
O	1846	1854	vimentin	vimentin	NN	B-NP
O	1855	1863	positive	positive	JJ	B-ADJP
O	1864	1867	and	and	CC	O
O	1868	1872	also	also	RB	B-ADJP
O	1873	1881	positive	positive	JJ	I-ADJP
O	1882	1885	for	for	IN	B-PP
O	1886	1887	a	a	DT	B-NP
O	1888	1898	monoclonal	monoclonal	JJ	I-NP
O	1899	1907	antibody	antibody	NN	I-NP
O	1908	1915	against	against	IN	B-PP
O	1916	1924	specific	specific	JJ	B-NP
B-Cell	1925	1935	fibroblast	fibroblast	NN	I-NP
O	1936	1943	antigen	antigen	NN	I-NP
O	1944	1945	(	(	(	O
O	1945	1950	clone	clone	NN	B-NP
O	1951	1955	ASO2	ASO2	NN	I-NP
O	1955	1956	,	,	,	O
O	1957	1964	Dianova	Dianova	NNP	B-NP
O	1964	1965	,	,	,	O
O	1966	1973	Hamburg	Hamburg	NNP	B-NP
O	1973	1974	,	,	,	O
O	1975	1982	Germany	Germany	NNP	B-NP
O	1982	1983	)	)	)	O
O	1983	1984	.	.	.	O

O	1985	1990	Owing	Owe	VBG	B-VP
O	1991	1993	to	to	TO	B-PP
O	1994	1997	the	the	DT	B-NP
O	1998	2005	limited	limit	VBN	I-NP
O	2006	2012	amount	amount	NN	I-NP
O	2013	2015	of	of	IN	B-PP
B-Cell	2016	2021	cells	cell	NNS	B-NP
O	2021	2022	,	,	,	O
O	2023	2027	only	only	RB	B-NP
O	2028	2031	DNA	DNA	NN	I-NP
O	2032	2035	was	be	VBD	B-VP
O	2036	2045	extracted	extract	VBN	I-VP
O	2045	2046	.	.	.	O

